In summarizing this study, we affirm that our risk assessment model, based on PADGs, specifically APP, THBS1, F13A1, SRC, PPBP, and VCL, presents robust diagnostic capabilities for stroke patients. The gene discussed is F13A1; the disease is stroke disorder.